SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-018381
Filing Date
2023-05-05
Accepted
2023-05-05 17:02:07
Documents
12
Period of Report
2023-05-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20230502.htm   iXBRL 8-K 51819
  Complete submission text file 0000950170-23-018381.txt   168626

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20230502.xsd EX-101.SCH 2454
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20230502_lab.xml EX-101.LAB 13350
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20230502_pre.xml EX-101.PRE 9830
6 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20230502_htm.xml XML 4691
Mailing Address 4 CORPORATE DRIVE ANDOVER MA 01810
Business Address 4 CORPORATE DRIVE ANDOVER MA 01810 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 23894834
SIC: 2834 Pharmaceutical Preparations